Universal Display Corporation: Q1 2023 Form 10-Q Summary
Business Context and Reporting Period
Universal Display Corporation develops, licenses and commercializes OLED technologies and materials for display and lighting applications. Revenue is generated primarily from OLED material sales, royalty and license fees, and contract research services through Adesis. The filing covers the unaudited three months ended March 31, 2023, compared with the three months ended March 31, 2022.
Key Financial Metrics
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Total revenue | $130.5 million | $150.5 million | Down $20.0 million, 13% |
| Material sales | $70.2 million | $86.7 million | Down 19% |
| Royalty and license fees | $55.2 million | $59.8 million | Down 8% |
| Contract research services | $5.1 million | $4.0 million | Up 27% |
| Gross margin | $97.5 million | $117.3 million | Down 17% |
| Gross margin percentage | 74.7% | 78.0% | Down 3.3 percentage points |
| Operating income | $45.4 million | $62.3 million | Down 27% |
| Operating margin | 34.8% | 41.4% | Down 6.6 percentage points |
| Net income | $39.8 million | $50.0 million | Down 20% |
| Diluted EPS | $0.83 | $1.05 | Down $0.22 |
| Operating cash flow | $47.6 million | $52.6 million | Down $5.0 million |
Interest income increased to $7.0 million from $0.3 million because of higher bond yields and larger available-for-sale investment balances. The effective tax rate increased to 22.8% from 20.1%.
Liquidity, Capitalization and Cash Flow
- Cash and cash equivalents were $158.3 million at March 31, 2023, compared with $93.4 million at December 31, 2022.
- Short-term investments were $487.8 million and long-term bond investments were $199.3 million, resulting in total cash and investments of approximately $845.4 million.
- Working capital was $835.3 million, up from $763.8 million at year-end 2022.
- The filing does not report outstanding borrowings or traditional debt. Total liabilities were $236.2 million, including $30.6 million of operating lease liabilities and $60.2 million of retirement plan benefit liability.
- Operating activities provided $47.6 million; investing activities provided $40.7 million, primarily from net investment maturities and sales; financing activities used $23.4 million, including $16.8 million of dividends and $7.2 million of employee tax withholding payments.
- The company declared and paid a quarterly common-stock dividend of $0.35 per share and declared a second-quarter dividend of $0.35 per share payable June 30, 2023.
Material Changes Versus the Prior Comparable Period
- Material sales declined 19%, with unit material volume down 18%, primarily because of reduced emitter-material demand and unfavorable macroeconomic conditions affecting the OLED display market.
- Green emitter sales declined to $53.7 million from $66.4 million, while red emitter sales declined to $16.1 million from $20.2 million.
- Royalty and license fees declined 8%, primarily due to lower customer material volumes. A $5.7 million cumulative catch-up adjustment increased recognized revenue because lower anticipated customer demand raised the estimated average price per gram over remaining contract lives.
- Cost of sales was broadly stable despite lower revenue. Shannon, Ireland manufacturing-facility underutilization charges were $4.7 million, and the company recorded a $3.3 million inventory reserve increase versus $84,000 in the prior-year quarter.
- Research and development expense increased 18% to $31.4 million, driven by higher operating, PPG development and employee-related costs.
- Selling, general and administrative expense decreased 27% to $15.4 million, primarily because of lower stock-based compensation and lower Shannon pre-production costs.
- Amortization expense decreased by $2.6 million because the Fujifilm patents became fully amortized in July 2022.
Guidance, Outlook, Risks and Unusual Items
Management did not provide specific quantitative revenue or earnings guidance in the filing. Management expects material-sales weakness to be temporary but states that the timing of recovery in global market conditions remains uncertain. The Shannon facility is expected to expand production capacity and diversify manufacturing, but management expects near-term underutilization as capacity is brought online for anticipated future growth.
- Revenue and results may fluctuate based on customer OLED production, material volumes, royalty timing, research and development spending, patent activity and new business relationships.
- Macroeconomic conditions, higher interest rates, inflationary pressures and weaker consumer demand have reduced customer demand and production requirements.
- Customer concentration is significant: three customers represented 30%, 26% and 21% of Q1 2023 revenue, respectively. Approximately 97% of revenue was generated outside North America.
- Substantially all chemical materials were purchased from one supplier, creating supply-chain concentration risk.
- Inventory reserves may increase if demand is lower than forecasts. The company had $33.9 million of firm inventory purchase commitments at March 31, 2023.
- The company has approximately $19.6 million of committed phosphorescent-emitter material backlog expected to be fulfilled within 90 days.
- The company expects sufficient cash, cash equivalents and short-term investments to meet obligations for at least the next twelve months, while noting that future financing could be required for research, development, commercialization and patent activities.
- On April 28, 2023, UDC Ireland agreed to purchase OLED-related patents and patent applications from Merck KGaA for $66.0 million in cash.
- The company recorded a $1.0 million foreign-exchange loss in Q1 2023 related to remeasurement of a Korean tax-refund receivable. The estimated tax-refund and related U.S. tax consequences remain subject to change and settlement.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting. No material changes were reported to previously disclosed risk factors.
Important Facts for Investors to Verify
- Whether OLED display demand and customer material volumes recover, particularly in South Korea and China.
- The sustainability and timing of the $5.7 million revenue catch-up adjustment and the assumptions for customer demand over remaining contract terms.
- The duration and financial impact of Shannon facility underutilization and the pace of production ramp-up.
- Inventory utilization and the potential for additional reserves beyond the $3.3 million Q1 charge.
- Customer concentration, supplier concentration and the contractual minimums and purchase obligations under major license and supply agreements.
- The cash impact and strategic value of the $66.0 million Merck patent acquisition.
- The outcome and timing of Korean withholding-tax refund claims, amended U.S. tax returns and related tax liabilities.